Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Tranexamic Acid on Blood Loss During Percutaneous Nephrolithotomy
NCT04367155Unknown
- Sponsor
- Kafrelsheikh University
- Start
- Sep 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in nephrolithiasis (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Value of tranexamic acid at 12 months. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT04367155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04367155.